InvestorsHub Logo
Followers 14
Posts 1044
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Tuesday, 03/05/2019 9:19:46 AM

Tuesday, March 05, 2019 9:19:46 AM

Post# of 3854
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
-- Patent covers use of cannabinoids and terpenes for treatment of
organophosphate and carbamate toxicity --

https://files.constantcontact.com/8d9857b2301/60a4bdcb-e585-45ee-8710-b2474cc6a8ee.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NXEN News